Search
Oric Pharmaceuticals Inc
ORICAdd to Watchlist
12.955USD
-0.375-2.81%
Market hours 09/24, 10:59（ET）
1.34BMarket Cap
LossP/E TTM
Oric Pharmaceuticals Inc (ORIC) Stock Price Target & Forecast
Analyst Rating
Based on 15 analysts giving stock ratings to Oric Pharmaceuticals Inc in the past month.
Buy
7 Strong Buy
7 Buy
1 Hold
0 Sell
0 Strong Sell
Target Price
20.917USD+54.94%
ORIC Analyst Recommendation Trends
In the current month, ORIC has received 7 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. ORIC average Analyst price target in the last month is 20.917.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
7
7
7
7
7
7
7
7
7
8
7
7
7
7
6
6
1
1
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
15
16
15
15
15
15
14
14
Financial Forecasting
Based on analysts' estimates, ORIC EPS is projected to reach -0.381 in FY2026Q3, following reported EPS of -0.384 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.36
-0.32
-0.36
-0.38
-0.40
Actual
-0.30
-0.34
-0.38
--
--
Surprise
+18.41%
-4.42%
-6.26%
--
--
FAQs
What is Oric Pharmaceuticals Inc's price target?
Analysts forecast that Oric Pharmaceuticals Inc's price target is USD 19.50, with the highest forecast at USD 25.00 and the lowest forecast at USD 12.00.
How have Oric Pharmaceuticals IncORIC's recent earnings per share performed?
The market expectation was USD -0.38, while Oric Pharmaceuticals IncORIC's earnings per share (EPS) for the previous quarter was USD -0.34. EPS for the next quarter is expected at USD -0.38.
What is the analyst rating for Oric Pharmaceuticals Inc?
Based on the ratings of Oric Pharmaceuticals Inc's stock from 15 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.